Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)

Rudolf Stadler; Pablo Ortiz Romero; Martine Bagot; Pietro Quaglino; Emmanuella Guenova; Constanze Jonak; Evangelina Papadavid; René Stranzenbach; Delphine Sartori; Jammbe Z Musoro; Claudette Falato; Sandrine Marreaud; Julia Jane Scarisbrick; Robert Knobler

doi:10.1016/S0959-8049(21)00668-7

Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)

Rudolf Stadler
, Pablo Ortiz Romero
, Martine Bagot
, Pietro Quaglino
, Emmanuella Guenova
, Constanze Jonak
, Evangelina Papadavid
, René Stranzenbach
, Delphine Sartori
, Jammbe Z Musoro
, Claudette Falato
, Sandrine Marreaud
, Julia Jane Scarisbrick
, Robert Knobler

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	S22-S23
Fachzeitschrift	European Journal of Cancer
Volume	156
Ausgabenummer	S1
DOIs	https://doi.org/10.1016/S0959-8049(21)00668-7
Publikationsstatus	Veröffentlicht - Okt. 2021
Extern publiziert	Ja

Wissenschaftszweige

302 Klinische Medizin

Zugriff auf Dokument

10.1016/S0959-8049(21)00668-7

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Stadler, R., Romero, P. O., Bagot, M., Quaglino, P., Guenova, E., Jonak, C., Papadavid, E., Stranzenbach, R., Sartori, D., Musoro, J. Z., Falato, C., Marreaud, S., Scarisbrick, J. J., & Knobler, R. (2021). Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT). European Journal of Cancer, 156(S1), S22-S23. https://doi.org/10.1016/S0959-8049(21)00668-7

@article{9eef53a85cfd42499edf4a8dd04d9979,

title = "Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/S{\'e}zary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)",

author = "Rudolf Stadler and Romero, \{Pablo Ortiz\} and Martine Bagot and Pietro Quaglino and Emmanuella Guenova and Constanze Jonak and Evangelina Papadavid and Ren{\'e} Stranzenbach and Delphine Sartori and Musoro, \{Jammbe Z\} and Claudette Falato and Sandrine Marreaud and Scarisbrick, \{Julia Jane\} and Robert Knobler",

year = "2021",

month = oct,

doi = "10.1016/S0959-8049(21)00668-7",

language = "English",

volume = "156",

pages = "S22--S23",

journal = "European Journal of Cancer",

issn = "1879-0852",

publisher = "Elsevier",

number = "S1",

}

Stadler, R, Romero, PO, Bagot, M, Quaglino, P, Guenova, E, Jonak, C, Papadavid, E, Stranzenbach, R, Sartori, D, Musoro, JZ, Falato, C, Marreaud, S, Scarisbrick, JJ & Knobler, R 2021, 'Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)', European Journal of Cancer, Jg. 156, Nr. S1, S. S22-S23. https://doi.org/10.1016/S0959-8049(21)00668-7

Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT). / Stadler, Rudolf; Romero, Pablo Ortiz; Bagot, Martine et al.
in: European Journal of Cancer, Volume 156, Nr. S1, 10.2021, S. S22-S23.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)

AU - Stadler, Rudolf

AU - Romero, Pablo Ortiz

AU - Bagot, Martine

AU - Quaglino, Pietro

AU - Guenova, Emmanuella

AU - Jonak, Constanze

AU - Papadavid, Evangelina

AU - Stranzenbach, René

AU - Sartori, Delphine

AU - Musoro, Jammbe Z

AU - Falato, Claudette

AU - Marreaud, Sandrine

AU - Scarisbrick, Julia Jane

AU - Knobler, Robert

PY - 2021/10

Y1 - 2021/10

UR - https://www.scopus.com/pages/publications/85116568770

U2 - 10.1016/S0959-8049(21)00668-7

DO - 10.1016/S0959-8049(21)00668-7

M3 - Article

C2 - 34649647

SN - 1879-0852

VL - 156

SP - S22-S23

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - S1

ER -